Compile Data Set for Download or QSAR
maximum 50k data
Found 2684 with Last Name = 'hutchinson' and Initial = 'jh'
TargetAdenosine receptor A3(Homo sapiens (Human))
Biointervene

US Patent
LigandPNGBDBM642632(US20230416245, Compound 70)
Affinity DataKi:  0.133nMAssay Description:Radioligand-binding assays were performed using the adenosine A3 receptor agonist [125I]-AB-MECA and the A1 receptor agonist [3H]CCPA. Binding assays...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A3(Homo sapiens (Human))
Biointervene

US Patent
LigandPNGBDBM642621(US20230416245, Compound 59)
Affinity DataKi:  0.230nMAssay Description:Radioligand-binding assays were performed using the adenosine A3 receptor agonist [125I]-AB-MECA and the A1 receptor agonist [3H]CCPA. Binding assays...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A3(Homo sapiens (Human))
Biointervene

US Patent
LigandPNGBDBM642624(US20230416245, Compound 62)
Affinity DataKi:  0.330nMAssay Description:Radioligand-binding assays were performed using the adenosine A3 receptor agonist [125I]-AB-MECA and the A1 receptor agonist [3H]CCPA. Binding assays...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A3(Homo sapiens (Human))
Biointervene

US Patent
LigandPNGBDBM642626(US20230416245, Compound 64)
Affinity DataKi:  0.640nMAssay Description:Radioligand-binding assays were performed using the adenosine A3 receptor agonist [125I]-AB-MECA and the A1 receptor agonist [3H]CCPA. Binding assays...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A3(Homo sapiens (Human))
Biointervene

US Patent
LigandPNGBDBM642625(US20230416245, Compound 63)
Affinity DataKi:  0.720nMAssay Description:Radioligand-binding assays were performed using the adenosine A3 receptor agonist [125I]-AB-MECA and the A1 receptor agonist [3H]CCPA. Binding assays...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A3(Homo sapiens (Human))
Biointervene

US Patent
LigandPNGBDBM642618(US20230416245, Compound 45)
Affinity DataKi:  1.30nMAssay Description:Radioligand-binding assays were performed using the adenosine A3 receptor agonist [125I]-AB-MECA and the A1 receptor agonist [3H]CCPA. Binding assays...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A3(Homo sapiens (Human))
Biointervene

US Patent
LigandPNGBDBM642635(US20230416245, Compound 83)
Affinity DataKi:  1.62nMAssay Description:Radioligand-binding assays were performed using the adenosine A3 receptor agonist [125I]-AB-MECA and the A1 receptor agonist [3H]CCPA. Binding assays...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A3(Homo sapiens (Human))
Biointervene

US Patent
LigandPNGBDBM642631(US20230416245, Compound 69)
Affinity DataKi:  1.68nMAssay Description:Radioligand-binding assays were performed using the adenosine A3 receptor agonist [125I]-AB-MECA and the A1 receptor agonist [3H]CCPA. Binding assays...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A3(Homo sapiens (Human))
Biointervene

US Patent
LigandPNGBDBM642620(US20230416245, Compound 35)
Affinity DataKi:  1.70nMAssay Description:Radioligand-binding assays were performed using the adenosine A3 receptor agonist [125I]-AB-MECA and the A1 receptor agonist [3H]CCPA. Binding assays...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A3(Homo sapiens (Human))
Biointervene

US Patent
LigandPNGBDBM642615(US20230416245, Compound 40)
Affinity DataKi:  2nMAssay Description:Radioligand-binding assays were performed using the adenosine A3 receptor agonist [125I]-AB-MECA and the A1 receptor agonist [3H]CCPA. Binding assays...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A3(Homo sapiens (Human))
Biointervene

US Patent
LigandPNGBDBM642636(US20230416245, Compound 90)
Affinity DataKi:  2.42nMAssay Description:Radioligand-binding assays were performed using the adenosine A3 receptor agonist [125I]-AB-MECA and the A1 receptor agonist [3H]CCPA. Binding assays...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A3(Homo sapiens (Human))
Biointervene

US Patent
LigandPNGBDBM642639(US20230416245, Compound 93)
Affinity DataKi:  2.59nMAssay Description:Radioligand-binding assays were performed using the adenosine A3 receptor agonist [125I]-AB-MECA and the A1 receptor agonist [3H]CCPA. Binding assays...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A3(Homo sapiens (Human))
Biointervene

US Patent
LigandPNGBDBM642627(US20230416245, Compound 65)
Affinity DataKi:  3.49nMAssay Description:Radioligand-binding assays were performed using the adenosine A3 receptor agonist [125I]-AB-MECA and the A1 receptor agonist [3H]CCPA. Binding assays...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A3(Homo sapiens (Human))
Biointervene

US Patent
LigandPNGBDBM642630(US20230416245, Compound 68)
Affinity DataKi:  4.75nMAssay Description:Radioligand-binding assays were performed using the adenosine A3 receptor agonist [125I]-AB-MECA and the A1 receptor agonist [3H]CCPA. Binding assays...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A3(Homo sapiens (Human))
Biointervene

US Patent
LigandPNGBDBM642634(US20230416245, Compound 82)
Affinity DataKi:  4.77nMAssay Description:Radioligand-binding assays were performed using the adenosine A3 receptor agonist [125I]-AB-MECA and the A1 receptor agonist [3H]CCPA. Binding assays...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A3(Homo sapiens (Human))
Biointervene

US Patent
LigandPNGBDBM642637(US20230416245, Compound 91)
Affinity DataKi:  5.10nMAssay Description:Radioligand-binding assays were performed using the adenosine A3 receptor agonist [125I]-AB-MECA and the A1 receptor agonist [3H]CCPA. Binding assays...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A3(Homo sapiens (Human))
Biointervene

US Patent
LigandPNGBDBM642623(US20230416245, Compound 61)
Affinity DataKi:  7.15nMAssay Description:Radioligand-binding assays were performed using the adenosine A3 receptor agonist [125I]-AB-MECA and the A1 receptor agonist [3H]CCPA. Binding assays...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A3(Homo sapiens (Human))
Biointervene

US Patent
LigandPNGBDBM642619(US20230416245, Compound 46)
Affinity DataKi:  21.3nMAssay Description:Radioligand-binding assays were performed using the adenosine A3 receptor agonist [125I]-AB-MECA and the A1 receptor agonist [3H]CCPA. Binding assays...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A3(Homo sapiens (Human))
Biointervene

US Patent
LigandPNGBDBM642638(US20230416245, Compound 92)
Affinity DataKi:  26.8nMAssay Description:Radioligand-binding assays were performed using the adenosine A3 receptor agonist [125I]-AB-MECA and the A1 receptor agonist [3H]CCPA. Binding assays...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A3(Homo sapiens (Human))
Biointervene

US Patent
LigandPNGBDBM642617(US20230416245, Compound 44)
Affinity DataKi:  28.4nMAssay Description:Radioligand-binding assays were performed using the adenosine A3 receptor agonist [125I]-AB-MECA and the A1 receptor agonist [3H]CCPA. Binding assays...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A3(Homo sapiens (Human))
Biointervene

US Patent
LigandPNGBDBM642629(US20230416245, Compound 67)
Affinity DataKi:  94.4nMAssay Description:Radioligand-binding assays were performed using the adenosine A3 receptor agonist [125I]-AB-MECA and the A1 receptor agonist [3H]CCPA. Binding assays...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A3(Homo sapiens (Human))
Biointervene

US Patent
LigandPNGBDBM642628(US20230416245, Compound 66)
Affinity DataKi:  126nMAssay Description:Radioligand-binding assays were performed using the adenosine A3 receptor agonist [125I]-AB-MECA and the A1 receptor agonist [3H]CCPA. Binding assays...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A3(Homo sapiens (Human))
Biointervene

US Patent
LigandPNGBDBM642633(US20230416245, Compound 71)
Affinity DataKi:  456nMAssay Description:Radioligand-binding assays were performed using the adenosine A3 receptor agonist [125I]-AB-MECA and the A1 receptor agonist [3H]CCPA. Binding assays...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAdenosine receptor A3(Homo sapiens (Human))
Biointervene

US Patent
LigandPNGBDBM642622(US20230416245, Compound 60)
Affinity DataKi: >9.40E+3nMAssay Description:Radioligand-binding assays were performed using the adenosine A3 receptor agonist [125I]-AB-MECA and the A1 receptor agonist [3H]CCPA. Binding assays...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50107412(3-(2-{2-Oxo-3-[2-(5,6,7,8-tetrahydro-[1,8]naphthyr...)
Affinity DataIC50:  0.0400nMAssay Description:Inhibition of high affinity radioligand binding to human alphaV-beta3 integrinMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50153027((S)-3-Pyrimidin-5-yl-9-(5,6,7,8-tetrahydro-[1,8]na...)
Affinity DataIC50:  0.0700nMAssay Description:Inhibitory activity against alpha v beta-3 receptor using scintillation proximity assay (SPAV3)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50134778((S)-3-(6-Methoxy-pyridin-3-yl)-3-{2-oxo-3-[3-(5,6,...)
Affinity DataIC50:  0.0800nMAssay Description:Inhibition of alphaV-beta3 integrin bindingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50153031((S)-3-(2-Methyl-pyrimidin-5-yl)-9-(5,6,7,8-tetrahy...)
Affinity DataIC50:  0.0800nMAssay Description:Inhibitory activity against alpha v beta-3 receptor using scintillation proximity assay (SPAV3)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50134777((S)-3-(2,3-Dihydro-benzofuran-6-yl)-3-{2-oxo-3-[3-...)
Affinity DataIC50:  0.100nMAssay Description:Inhibition of alphaV-beta3 integrin bindingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50152791((S)-2-((1S,4R)-7,7-Dimethyl-2-oxo-bicyclo[2.2.1]he...)
Affinity DataIC50:  0.100nMAssay Description:Inhibition of alpha v beta 3 receptor bindingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDimer of Protein farnesyltransferase subunit beta(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50081221(4-{5-[(S)-2-Butyl-4-(3-chloro-phenyl)-5-oxo-pipera...)
Affinity DataIC50:  0.110nMAssay Description:Inhibition of [3H]-FPP incorporation into recombinant human K-Ras by FarnesyltransferaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50153026((S)-3-(2-Methoxy-pyrimidin-5-yl)-9-(5,6,7,8-tetrah...)
Affinity DataIC50:  0.110nMAssay Description:Inhibitory activity against alpha v beta-3 receptor using scintillation proximity assay (SPAV3)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50107410(3-(2,3-Dihydro-benzofuran-6-yl)-3-(2-{2-oxo-3-[2-(...)
Affinity DataIC50:  0.110nMAssay Description:Inhibition of high affinity radioligand binding to human alphaV-beta3 integrinMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProtein farnesyltransferase subunit beta/geranylgeranyltransferase type-1 subunit alpha(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50072639((S)-2-(2-{[(S)-2-((R)-2-Amino-3-mercapto-propylami...)
Affinity DataIC50:  0.123nMAssay Description:Inhibition of [3H]- FPP incorporation into recombinant Ha-Ras by farnesyl transferase at 10 pMMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDimer of Protein farnesyltransferase subunit beta(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50081212(4-{5-[(S)-2-Butyl-5-oxo-4-(3-trifluoromethyl-pheno...)
Affinity DataIC50: >0.150nMAssay Description:Inhibition of [3H]-FPP incorporation into recombinant human K-Ras by FarnesyltransferaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDimer of Protein farnesyltransferase subunit beta(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50081215(4-{5-[(S)-4-(3-Chloro-phenyl)-2-ethanesulfonylmeth...)
Affinity DataIC50:  0.180nMAssay Description:Inhibition of [3H]-FPP incorporation into recombinant human K-Ras by FarnesyltransferaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50127938(3-(2-{6-Cyclopropyl-2-oxo-3-[(5,6,7,8-tetrahydro-[...)
Affinity DataIC50:  0.200nMAssay Description:Ability to bind to the Alpha 2 Beta 3 integrin expressed as inhibitory concentration against ADP-stimulated aggregation of human gel-filtered platele...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50127944((S)-3-Benzo[1,3]dioxol-5-yl-3-(2-{6-cyclopropyl-2-...)
Affinity DataIC50:  0.200nMAssay Description:Ability to bind to the Alpha 2 Beta 3 integrin expressed as inhibitory concentration against ADP-stimulated aggregation of human gel-filtered platele...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50153029((S)-3-Quinolin-3-yl-9-(5,6,7,8-tetrahydro-[1,8]nap...)
Affinity DataIC50:  0.200nMAssay Description:Inhibitory activity against alpha v beta-3 receptor using scintillation proximity assay (SPAV3)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50127939((S)-3-(2-{5-Chloro-6-cyclopropyl-2-oxo-3-[(5,6,7,8...)
Affinity DataIC50:  0.200nMAssay Description:Ability to bind to the Alpha 2 Beta 3 integrin expressed as inhibitory concentration against ADP-stimulated aggregation of human gel-filtered platele...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50127940((S)-3-(2-{6-Cyclopropyl-2-oxo-3-[(5,6,7,8-tetrahyd...)
Affinity DataIC50:  0.200nMAssay Description:Inhibitory activity against human alpha V beta3 receptor using SPAV3 assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50127947((S)-3-(2-{6-Cyclopropyl-2-oxo-3-[(5,6,7,8-tetrahyd...)
Affinity DataIC50:  0.200nMAssay Description:Inhibitory activity against human alpha V beta3 receptor using SPAV3 assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50153023((S)-3-(2,3-Dihydro-benzofuran-6-yl)-9-(5,6,7,8-tet...)
Affinity DataIC50:  0.210nMAssay Description:Inhibitory activity against alpha v beta-3 receptor using scintillation proximity assay (SPAV3)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50134780((S)-3-{2-Oxo-3-[3-(5,6,7,8-tetrahydro-[1,8]naphthy...)
Affinity DataIC50:  0.25nMAssay Description:Inhibition of alphaV-beta3 integrin bindingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50107411((S)-3-(2-Oxo-2,3-dihydro-benzooxazol-6-yl)-3-(2-{(...)
Affinity DataIC50:  0.290nMAssay Description:Inhibition of high affinity radioligand binding to human alphaV-beta3 integrinMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50121151(3-[5-(3-Cyclopropyl-5,6,7,8-tetrahydro-[1,8]naphth...)
Affinity DataIC50:  0.290nMAssay Description:Inhibition of binding to human integrin receptor alpha V beta3More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50127943((S)-3-(2-{5-Chloro-6-cyclopropyl-2-oxo-3-[(5,6,7,8...)
Affinity DataIC50:  0.300nMAssay Description:Ability to bind to the alpha IIb beta3 integrin expressed as inhibitory concentration against ADP-stimulated aggregation of human gel-filtered platel...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50152785((S)-2-Benzenesulfonylamino-3-(5-5,6,7,8-tetrahydro...)
Affinity DataIC50:  0.300nMAssay Description:Inhibition of alpha v beta 3 receptor bindingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetArachidonate 5-lipoxygenase-activating protein(Homo sapiens (Human))
Amira Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50359073(CHEMBL1922653)
Affinity DataIC50:  0.300nMAssay Description:Inhibition of FLAP in human peripheral leukocytes assessed as inhibition of calcium ionophore A23187-induced LTB4 production after 10 mins by ELISAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50142344((S)-3-(6-Methoxy-pyridin-3-yl)-3-{methyl-[5-(3-met...)
Affinity DataIC50:  0.300nMAssay Description:Displacement of [125I]L-775,219 from human recombinant alphaV-beta3 integrinMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 2684 total ) | Next | Last >>
Jump to: